SCHEMBL30123067

CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.55

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	7/20	0.55

▸	NPY2R	P49146	7/20	0.53

▸	NPY4R	P50391	7/20	0.53

▸	NPY5R	Q15761	7/20	0.53

▸	NPY1R	P25929	5/20	0.53

▸	RAMP3	O60896	3/20	0.52

▸	OPRM1	P35372	3/20	0.52

▸	OPRD1	P41143	3/20	0.52

▸	OPRK1	P41145	2/20	0.52

▸	CALCRL	Q16602	1/20	0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30607374	0.91	CALCR (0.58)	CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30163405	0.88	OPRM1 (0.56)	CALCRRAMP3OPRM1OPRD1OPRK1
SCHEMBL31232439	0.87	OPRM1 (0.63)	CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30429242	0.87	CALCR (0.63)	CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30163248	0.87	OPRM1 (0.55)	CALCRRAMP3OPRM1OPRD1OPRK1
SCHEMBL28846618	0.87	OPRM1 (0.55)	CALCRRAMP3OPRM1OPRD1OPRK1
SCHEMBL30163263	0.87	OPRM1 (0.55)	CALCRRAMP3OPRM1OPRD1OPRK1
SCHEMBL14549930	0.87	OPRM1 (0.55)	CALCRRAMP3OPRM1OPRD1OPRK1
SCHEMBL15130591	0.87	OPRM1 (0.55)	CALCRRAMP3OPRM1OPRD1OPRK1
SCHEMBL28210612	0.87	OPRM1 (0.55)	CALCRRAMP3OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4370150-A1	OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS	Intervet International B.V. (NL)	2024-05-22	—	—	EP	disclosed
WO-2023285489-A1	OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS	INTERVET INTERNATIONAL B.V. (NL)	2023-01-19	—	—	WO	disclosed